<i>Cyc</i> downregulation in circadian pacemaker neurons prevents the formation of sLN_vs axon bundles. by Grace Biondi (19924067)

Relative quantification of <i>mip</i> transcript levels in different developmental stages (A) and tissues (B) of brown planthopper. by Yi-Jie Zhang (713506)

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

The screening process of MN705. by Wencheng Jin (13136262)

Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. by Wencheng Jin (13136262)

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

Development of hamstring strength throughout the LIST. by Dominic Michael Rasp (19959412)

Development of the limb symmetry index (LSI) over the course of the LIST. by Dominic Michael Rasp (19959412)

Fig 3 - by Maha Rehman (17114332)

Growth of <i>Spirulina</i> spp. at 450nm for different temperature. by Maha Rehman (17114332)

Fig 5 - by Maha Rehman (17114332)

Fig 4 - by Maha Rehman (17114332)

Study-related adverse events. by Benjamin R. Lewis (22279166)

“…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …”

Study flow chart. by Benjamin R. Lewis (22279166)

“…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …”

Study CONSORT diagram. by Benjamin R. Lewis (22279166)

“…Safety was a study outcome and assessed by rate and severity of AEs and any incident suicidality or significant mental health symptoms. Baseline and outcome data were summarized using descriptive statistics, with continuous variables reported as means and standard deviations. …”

Baseline characteristics of the study sample^βμ. by Osama Mohamed Ibrahim (12006954)

“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”

The flow diagram of the study (CONSORT, 2010). by Osama Mohamed Ibrahim (12006954)

“…Pharmacists in Active Group A (37.2%) and Active Group B (32.3%) most commonly intervened by recommending the cessation of medication, while the most common intervention in the Control Group was recommending a decrease in dose (29.8%). The mean cost reduction per patient was highest in Active Group A (31.3 ±11.8 $), followed by Active Group B (20.8 ±8.6 $) and the Control Group (19.6 ±9.5 $). …”